Scleroderma Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: S4A9E7808C84EN
Market Monitor Global

Abstracts

Scleroderma is a umbrella term for a group of autoimmune diseases resulting in changes in blood vessels, skin, muscles, and other organs. The symptoms of Scleroderma include thickened and stiff skin, lethargy, and poor blood flow to extremities of the limbs such as fingers and toes on exposure to cold. Scleroderma can also result in deposition of calcium deposits, Raynaud's syndrome, and esophageal problems.

This report contains market size and forecasts of Scleroderma Drug in Global, including the following market information:

Global Scleroderma Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Scleroderma Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-inflammatory Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Scleroderma Drug include Cumberland Pharmaceuticals, Gilead Sciences, Pfizer, Sanofi, Boehringer Ingelheim, Corbus Pharmaceuticals, Actelion Pharmaceuticals, Bayer and Cytori Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Scleroderma Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Scleroderma Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Scleroderma Drug Market Segment Percentages, by Type, 2021 (%)

• Anti-inflammatory Agents
• Immunosuppressive Agents
• Anti-fibrotic Agents

Global Scleroderma Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Scleroderma Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Scleroderma Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Scleroderma Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Scleroderma Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Scleroderma Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cumberland Pharmaceuticals
• Gilead Sciences
• Pfizer
• Sanofi
• Boehringer Ingelheim
• Corbus Pharmaceuticals
• Actelion Pharmaceuticals
• Bayer
• Cytori Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Scleroderma Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Scleroderma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SCLERODERMA DRUG OVERALL MARKET SIZE

2.1 Global Scleroderma Drug Market Size: 2021 VS 2028
2.2 Global Scleroderma Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Scleroderma Drug Players in Global Market
3.2 Top Global Scleroderma Drug Companies Ranked by Revenue
3.3 Global Scleroderma Drug Revenue by Companies
3.4 Top 3 and Top 5 Scleroderma Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Scleroderma Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Scleroderma Drug Players in Global Market
  3.6.1 List of Global Tier 1 Scleroderma Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Scleroderma Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Scleroderma Drug Market Size Markets, 2021 & 2028
  4.1.2 Anti-inflammatory Agents
  4.1.3 Immunosuppressive Agents
  4.1.4 Anti-fibrotic Agents
4.2 By Type - Global Scleroderma Drug Revenue & Forecasts
  4.2.1 By Type - Global Scleroderma Drug Revenue, 2017-2022
  4.2.2 By Type - Global Scleroderma Drug Revenue, 2023-2028
  4.2.3 By Type - Global Scleroderma Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Scleroderma Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Scleroderma Drug Revenue & Forecasts
  5.2.1 By Application - Global Scleroderma Drug Revenue, 2017-2022
  5.2.2 By Application - Global Scleroderma Drug Revenue, 2023-2028
  5.2.3 By Application - Global Scleroderma Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Scleroderma Drug Market Size, 2021 & 2028
6.2 By Region - Global Scleroderma Drug Revenue & Forecasts
  6.2.1 By Region - Global Scleroderma Drug Revenue, 2017-2022
  6.2.2 By Region - Global Scleroderma Drug Revenue, 2023-2028
  6.2.3 By Region - Global Scleroderma Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Scleroderma Drug Revenue, 2017-2028
  6.3.2 US Scleroderma Drug Market Size, 2017-2028
  6.3.3 Canada Scleroderma Drug Market Size, 2017-2028
  6.3.4 Mexico Scleroderma Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Scleroderma Drug Revenue, 2017-2028
  6.4.2 Germany Scleroderma Drug Market Size, 2017-2028
  6.4.3 France Scleroderma Drug Market Size, 2017-2028
  6.4.4 U.K. Scleroderma Drug Market Size, 2017-2028
  6.4.5 Italy Scleroderma Drug Market Size, 2017-2028
  6.4.6 Russia Scleroderma Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Scleroderma Drug Market Size, 2017-2028
  6.4.8 Benelux Scleroderma Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Scleroderma Drug Revenue, 2017-2028
  6.5.2 China Scleroderma Drug Market Size, 2017-2028
  6.5.3 Japan Scleroderma Drug Market Size, 2017-2028
  6.5.4 South Korea Scleroderma Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Scleroderma Drug Market Size, 2017-2028
  6.5.6 India Scleroderma Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Scleroderma Drug Revenue, 2017-2028
  6.6.2 Brazil Scleroderma Drug Market Size, 2017-2028
  6.6.3 Argentina Scleroderma Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Scleroderma Drug Revenue, 2017-2028
  6.7.2 Turkey Scleroderma Drug Market Size, 2017-2028
  6.7.3 Israel Scleroderma Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Scleroderma Drug Market Size, 2017-2028
  6.7.5 UAE Scleroderma Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cumberland Pharmaceuticals
  7.1.1 Cumberland Pharmaceuticals Corporate Summary
  7.1.2 Cumberland Pharmaceuticals Business Overview
  7.1.3 Cumberland Pharmaceuticals Scleroderma Drug Major Product Offerings
  7.1.4 Cumberland Pharmaceuticals Scleroderma Drug Revenue in Global Market (2017-2022)
  7.1.5 Cumberland Pharmaceuticals Key News
7.2 Gilead Sciences
  7.2.1 Gilead Sciences Corporate Summary
  7.2.2 Gilead Sciences Business Overview
  7.2.3 Gilead Sciences Scleroderma Drug Major Product Offerings
  7.2.4 Gilead Sciences Scleroderma Drug Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Scleroderma Drug Major Product Offerings
  7.3.4 Pfizer Scleroderma Drug Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Scleroderma Drug Major Product Offerings
  7.4.4 Sanofi Scleroderma Drug Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Boehringer Ingelheim
  7.5.1 Boehringer Ingelheim Corporate Summary
  7.5.2 Boehringer Ingelheim Business Overview
  7.5.3 Boehringer Ingelheim Scleroderma Drug Major Product Offerings
  7.5.4 Boehringer Ingelheim Scleroderma Drug Revenue in Global Market (2017-2022)
  7.5.5 Boehringer Ingelheim Key News
7.6 Corbus Pharmaceuticals
  7.6.1 Corbus Pharmaceuticals Corporate Summary
  7.6.2 Corbus Pharmaceuticals Business Overview
  7.6.3 Corbus Pharmaceuticals Scleroderma Drug Major Product Offerings
  7.6.4 Corbus Pharmaceuticals Scleroderma Drug Revenue in Global Market (2017-2022)
  7.6.5 Corbus Pharmaceuticals Key News
7.7 Actelion Pharmaceuticals
  7.7.1 Actelion Pharmaceuticals Corporate Summary
  7.7.2 Actelion Pharmaceuticals Business Overview
  7.7.3 Actelion Pharmaceuticals Scleroderma Drug Major Product Offerings
  7.7.4 Actelion Pharmaceuticals Scleroderma Drug Revenue in Global Market (2017-2022)
  7.7.5 Actelion Pharmaceuticals Key News
7.8 Bayer
  7.8.1 Bayer Corporate Summary
  7.8.2 Bayer Business Overview
  7.8.3 Bayer Scleroderma Drug Major Product Offerings
  7.8.4 Bayer Scleroderma Drug Revenue in Global Market (2017-2022)
  7.8.5 Bayer Key News
7.9 Cytori Therapeutics
  7.9.1 Cytori Therapeutics Corporate Summary
  7.9.2 Cytori Therapeutics Business Overview
  7.9.3 Cytori Therapeutics Scleroderma Drug Major Product Offerings
  7.9.4 Cytori Therapeutics Scleroderma Drug Revenue in Global Market (2017-2022)
  7.9.5 Cytori Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Scleroderma Drug Market Opportunities & Trends in Global Market
Table 2. Scleroderma Drug Market Drivers in Global Market
Table 3. Scleroderma Drug Market Restraints in Global Market
Table 4. Key Players of Scleroderma Drug in Global Market
Table 5. Top Scleroderma Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Scleroderma Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Scleroderma Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Scleroderma Drug Product Type
Table 9. List of Global Tier 1 Scleroderma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Scleroderma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Scleroderma Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Scleroderma Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Scleroderma Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Scleroderma Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Scleroderma Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Scleroderma Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Scleroderma Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Scleroderma Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Scleroderma Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Scleroderma Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Scleroderma Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Scleroderma Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Scleroderma Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Scleroderma Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Scleroderma Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Scleroderma Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Scleroderma Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Scleroderma Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Scleroderma Drug Revenue, (US$, Mn), 2023-2028
Table 30. Cumberland Pharmaceuticals Corporate Summary
Table 31. Cumberland Pharmaceuticals Scleroderma Drug Product Offerings
Table 32. Cumberland Pharmaceuticals Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences Scleroderma Drug Product Offerings
Table 35. Gilead Sciences Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Scleroderma Drug Product Offerings
Table 38. Pfizer Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Scleroderma Drug Product Offerings
Table 41. Sanofi Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim Corporate Summary
Table 43. Boehringer Ingelheim Scleroderma Drug Product Offerings
Table 44. Boehringer Ingelheim Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 45. Corbus Pharmaceuticals Corporate Summary
Table 46. Corbus Pharmaceuticals Scleroderma Drug Product Offerings
Table 47. Corbus Pharmaceuticals Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 48. Actelion Pharmaceuticals Corporate Summary
Table 49. Actelion Pharmaceuticals Scleroderma Drug Product Offerings
Table 50. Actelion Pharmaceuticals Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Scleroderma Drug Product Offerings
Table 53. Bayer Scleroderma Drug Revenue (US$, Mn), (2017-2022)
Table 54. Cytori Therapeutics Corporate Summary
Table 55. Cytori Therapeutics Scleroderma Drug Product Offerings
Table 56. Cytori Therapeutics Scleroderma Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Scleroderma Drug Segment by Type in 2021
Figure 2. Scleroderma Drug Segment by Application in 2021
Figure 3. Global Scleroderma Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Scleroderma Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Scleroderma Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Scleroderma Drug Revenue in 2021
Figure 8. By Type - Global Scleroderma Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Scleroderma Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Scleroderma Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Scleroderma Drug Revenue Market Share, 2017-2028
Figure 12. US Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Scleroderma Drug Revenue Market Share, 2017-2028
Figure 16. Germany Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Scleroderma Drug Revenue Market Share, 2017-2028
Figure 24. China Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Scleroderma Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Scleroderma Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Scleroderma Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Cumberland Pharmaceuticals Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Corbus Pharmaceuticals Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Actelion Pharmaceuticals Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cytori Therapeutics Scleroderma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)